Login / Signup

Safety and efficacy of tumour-treating fields (TTFields) therapy for newly diagnosed glioblastoma in Japanese patients using the Novo-TTF System: a prospective post-approval study.

Ryo NishikawaFumiyuki YamasakiYoshiki ArakawaYoshihiro MuragakiYoshitaka NaritaShota TanakaShigeru YamaguchiAkitake MukasaMasayuki Kanamori
Published in: Japanese journal of clinical oncology (2023)
This post-approval, real-world evidence study revealed no new safety signals and suggests the safety and efficacy of tumour-treating fields therapy in Japanese patients with newly diagnosed glioblastoma.
Keyphrases
  • newly diagnosed
  • single cell
  • mesenchymal stem cells
  • drug administration